Filing Details

Accession Number:
0001209191-22-058295
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-11-21 21:04:40
Reporting Period:
2022-11-21
Accepted Time:
2022-11-21 21:04:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1339970 Atyr Pharma Inc LIFE Biological Products, (No Disgnostic Substances) (2836) 203435077
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1671026 Sanjay Shukla 3545 John Hopkins Court, Suite #250
San Diego CA 92121
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-11-21 10,000 $2.14 50,798 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Represents weighted average price for the shares. The shares were purchased at prices ranging from $2.13 to $2.16 per share. The reportingperson will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, fullinformation regarding the number of shares purchased at each separate price